Repurposing melatonin for its potential roles in gastrointestinal cancers: highlighting the molecular mechanisms
Kiana Yousefipour, Seyed Soheil Razavi Rohani, Sayed Mohammad Mahdi Hosseini, Kianaz Kafilzadeh, Nafiseh Sadat Alavi, Negar Firouzabadi · 2026
Read Repurposing melatonin for its potential roles in gastrointestinal cancers: highlighting the molecular mechanisms by Kiana Yousefipour, Seyed Soheil Razavi Rohani, Sayed Mohammad Mahdi Hosseini, Kianaz Kafilzadeh, Nafiseh Sadat Alavi, Negar Firouzabadi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13377805.txt.
Description
Kiana Yousefipour and others review repurposing melatonin as an adjunct for gastrointestinal cancers in a 2026 paper. Gastrointestinal cancers are common and often carry poor prognosis, while chemo toxicity and low compliance limit treatment. Melatonin, a hormone with low toxicity, shows antitumour effects by modifying signals pathways, blocking growth and spread, triggering cell death and self-eating, and cutting oxidative stress.
The review traces melatonin action across gastrointestinal cancers, emphasising its power to boost chemo effect while reducing toxicity. Because melatonin is already well characterised, it could be used off-label as an adjunct to improve prognosis and quality of life. The work gathers the gene case for trials testing melatonin alongside standard gastrointestinal cancer therapy.
Catalog record
| CREATOR | Kiana Yousefipour, Seyed Soheil Razavi Rohani, Sayed Mohammad Mahdi Hosseini, Kianaz Kafilzadeh, Nafiseh Sadat Alavi, Negar Firouzabadi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 85 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |